Projects IrsiCaixa is involved in a hundred national and international research projects active each year, funded by both public and private entities. Breadcrumb Home Keywords Research group - Any -Cell Virology and Immunology (VIC)HIV and HVC Genetic and Phenotypic VariabilityImmunology (IGG)Microbial Genomics (GEM)Neoantigens and Vaccines against Cancer (NeoVaCan)Pathogen Immunity, Signalling and Therapeutic Applications (PISTA)Retrovirology and Clinical Studies (GREC)T-cell Immunology and Vaccines (TIV)Tissue Virology (VITI)Translational Research in Immunology and Ageing (TRIA)Viral Immune Evasion and Vaccines (VIRIEVAC)Virus-Host Interactions (ViHIT) Researcher - Any -Aleix Elizalde TorrentAlejandro Riquelme GrauAlessandra BorgognoneAlex Olvera van der StoepAmaya Blanco PereraAnaí Villanueva DelgadoAnna López PlanaAnna Pons GrifolsArnau Creus OrodeaBeatriz Mothe PujadasBenjamin TrinitéBonaventura Clotet SalaCarla Rovirosa MartíCarlos Ávila NietoCarmen Aguilar GurrieriCecilia Cabrera NavarroChristian BranderCristina GálvezCristina Mesa RealCristina Peligero CruzCristina Ramírez SotoDàlia Raïch ReguéEdurne García VidalEdwards Pradenas SaavedraElena Lapaz LorenzoElisabet Fernández RosasElisabet García RodríguezElisabet Pallarés Elisa Molina MolinaEloi Franco Trepat Erola Ainsua EnrichEster Ballana GuixEudald Felip FalgàsEudald Vehí PiquéEulalia Grau SegúEva Armendariz BurgoaEva Riveira MuñozFernando Laguía NuedaFerran Abancó i EspugaFrancesc Català MollFrancesc Cunyat ViaplanaFrancisco M. Muñoz LópezGabriel Felipe Rodríguez LozanoGerard Campos GonzalezGooya BanaeiGustavo Rodríguez EstebanIgnasi Calba IñiguezIgor Moraes CardosoIrene González NavarroItziar Erkizia JauregiJakub ChojnackiJavier Martínez-PicadoJoan Pagès OliverasJon Izquierdo PujolJordi Senserrich VelascoJorge Carrillo MolinaJosé Luis Pérez GuillamónJudith Dalmau MorenoJulia García PradoJulià Blanco ArbuésJulián Eslava CampoJúlia Albó DelgadoLaia Bernad RosaLaia Vives AdriánLaura Planells FerrerLidia Garrido SanzLidia Ruiz TabuencaLluís Revilla SanchoLourdes Grau ParéLucía Gómez EspadaMacedonia Trigueros PeñaManel Garcia de la FuenteMarc Noguera i JulianMaria Casadellà FontdevilaMaria Nevot BanúsMaria Salgado BernalMarina Martinez VelascoMarina Matilla MartínezMarina Pino CebriánMariona Parera SallentMarissa Flores SantamaríaMarta Massanella LunaMarta Ruiz RiolMaría Lázaro DíezMiguel Ángel Martínez de la SierraMireia Martínez GameroMª Carmen García GuerreroMª Carmen Puertas CastroMª Luisa Rodríguez de la ConcepciónNatàlia Marrugat VilaNel Marín SánchezNuria Izquierdo UserosNúria de la Iglesia ZaragozaNúria Pedreño LópezOriol Careta BorràsPatricia Piñol JuradoPatricia Resa InfantePenélope Riquelme NevadoRafaela Ayen AparicioRaúl Pérez CaballeroRita Casas CostaRoger Badia CórcolesRoger ParedesRosina Malagrida EscalasRuth Peña PoderósRytis BoreikaSamandhy Cedeño BriceñoSandra Franco CireraSara Cabrero de las HerasSara Morón LópezSilvia Marfil VerchiliSonia Bange SinghSonia Villanueva HernándezSusana Esteban RayaSílvia Ribó GenéTeresa Puig OlivaTetyana PidkovaThuong NguyenTuixent Escribà BelValentina Triviño VenceVíctor Urrea GalesÁngel Bayón Gil From date To date RBD Dimer recombinant protein vaccine against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Marta Ruiz Riol Julià Blanco Arbués Christian Brander Jorge Carrillo Molina Samandhy Cedeño Briceño Julia García Prado Nuria Izquierdo Useros Tuixent Escribà Bel Eulalia Grau Segú Beatriz Mothe Pujadas Strategic lines Cancer Emerging infectious diseases Financing entity European Commission Codi: 101046118 Incorporation of a new subject and new groups to the Consortium of the Centro de Investigación Biomédica en Red M.P. (CIBER) Project status Ongoing Start/End 2022 Principal investigator Julia García Prado Javier Martínez-Picado Participating entities IrsiCaixa, IGTP Financing entity ISCIII Enhancing Tissue-Specific Immune Microenvironments for the Cure of HIV. ETI-CURE “La Caixa” Health Research HR20-00218 Project status Ongoing Start/End 2021 / 2024 Principal investigator Julia García Prado Participating entities Irsicaixa / VHIR / Universidad Autónoma de Madrid Financing entity ETI-CURE “La Caixa” Health Research DURVAST: A phase II exploratory study of durvalumab (MEDI4736) in HIV-1 patients with advanced solid tumors Project status Ongoing Start/End 2017 / 2019 Principal investigator Javier Martínez-Picado Participating entities Spanish Lung Cancer Cooperative Group & IrsiCaixa AIDS Research Institute. Financing entity AstraZeneca Translational study of Inhibitory Receptors in HIV-1 infection: Identification of novel immunotherapeutic targets to reverse T-cell immune exhaustion Project status Ongoing Start/End 2018 / 2020 Principal investigator Julia García Prado Participating entities Institut de Recerca de la Sida IrsiCaixa Financing entity Ministry of the Economy, Industry and Competitiveness - Carlos III Health Institute (ISCIII) – FEDER. PI17/00164 Preclinical evaluation of immunoregulatory molecules in combination with latency reactivators for the development of new HIV-1 erradication strategies Project status Ongoing Start/End 2015 / 2018 Principal investigator Julia García Prado Financing entity Ministry of the Economy and Competitiveness - Carlos III Health Institute (ISCIII) - FEDER. PI14/01058 LKR155762 Combine use of vaccines an immune check blockers to boost CTL activity against the reservoir Project status Ongoing Start/End 2017 / 2019 Principal investigator Julia García Prado Financing entity MSD Glicoingeniería de nanovehículos para eliminar los reservorios virales; saf2017-91767-exp Project status Ongoing Start/End Principal investigator Nuria Izquierdo Useros Participating entities Irsicaixa, ICN2, UPV-CSIC Financing entity MINECO Connecting innate and adaptive immunity via TRIM5 proteins for cellular resistance to HIV Project status Ongoing Start/End Principal investigator Julia García Prado Financing entity Beatriu de Pinós post-doctoral fellowship, AGAUR CELLRE - TRIM5-based gene therapy approaches for inducible cellular resistance to HIV-1 Project status Ongoing Start/End 2018 / 2023 Principal investigator Julia García Prado Financing entity Grifols Pagination 1 Page 2 Next Last
RBD Dimer recombinant protein vaccine against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Marta Ruiz Riol Julià Blanco Arbués Christian Brander Jorge Carrillo Molina Samandhy Cedeño Briceño Julia García Prado Nuria Izquierdo Useros Tuixent Escribà Bel Eulalia Grau Segú Beatriz Mothe Pujadas Strategic lines Cancer Emerging infectious diseases Financing entity European Commission Codi: 101046118
Incorporation of a new subject and new groups to the Consortium of the Centro de Investigación Biomédica en Red M.P. (CIBER) Project status Ongoing Start/End 2022 Principal investigator Julia García Prado Javier Martínez-Picado Participating entities IrsiCaixa, IGTP Financing entity ISCIII
Enhancing Tissue-Specific Immune Microenvironments for the Cure of HIV. ETI-CURE “La Caixa” Health Research HR20-00218 Project status Ongoing Start/End 2021 / 2024 Principal investigator Julia García Prado Participating entities Irsicaixa / VHIR / Universidad Autónoma de Madrid Financing entity ETI-CURE “La Caixa” Health Research
DURVAST: A phase II exploratory study of durvalumab (MEDI4736) in HIV-1 patients with advanced solid tumors Project status Ongoing Start/End 2017 / 2019 Principal investigator Javier Martínez-Picado Participating entities Spanish Lung Cancer Cooperative Group & IrsiCaixa AIDS Research Institute. Financing entity AstraZeneca
Translational study of Inhibitory Receptors in HIV-1 infection: Identification of novel immunotherapeutic targets to reverse T-cell immune exhaustion Project status Ongoing Start/End 2018 / 2020 Principal investigator Julia García Prado Participating entities Institut de Recerca de la Sida IrsiCaixa Financing entity Ministry of the Economy, Industry and Competitiveness - Carlos III Health Institute (ISCIII) – FEDER. PI17/00164
Preclinical evaluation of immunoregulatory molecules in combination with latency reactivators for the development of new HIV-1 erradication strategies Project status Ongoing Start/End 2015 / 2018 Principal investigator Julia García Prado Financing entity Ministry of the Economy and Competitiveness - Carlos III Health Institute (ISCIII) - FEDER. PI14/01058
LKR155762 Combine use of vaccines an immune check blockers to boost CTL activity against the reservoir Project status Ongoing Start/End 2017 / 2019 Principal investigator Julia García Prado Financing entity MSD
Glicoingeniería de nanovehículos para eliminar los reservorios virales; saf2017-91767-exp Project status Ongoing Start/End Principal investigator Nuria Izquierdo Useros Participating entities Irsicaixa, ICN2, UPV-CSIC Financing entity MINECO
Connecting innate and adaptive immunity via TRIM5 proteins for cellular resistance to HIV Project status Ongoing Start/End Principal investigator Julia García Prado Financing entity Beatriu de Pinós post-doctoral fellowship, AGAUR
CELLRE - TRIM5-based gene therapy approaches for inducible cellular resistance to HIV-1 Project status Ongoing Start/End 2018 / 2023 Principal investigator Julia García Prado Financing entity Grifols